Recent clinical studies explored the prognostic role of global longitudinal strain (GLS) in patients with known cardiovascular diseases. 5-10 GLS predicted all-cause mortality and cardiac events in patients with symptomatic heart failure (HF) and reduced 5-7 or preserved ejection fraction (EF). 8 Speckle tracking derived-GLS has also an independent prognostic value in patients with myocardial infarction. 9,10 On the contrary, population-based studies are essential to determine the prognostic significance of subclinical LV systolic dysfunction. To date, 2 community-based studies reported on the incremental predictive value of magnetic resonance imaging 11 or echocardioraphically 12 derived LV circumferential strain for incident HF and coronary heart disease. To our knowledge, Background-Techniques of 2-dimensional speckle tracking enable the measurement of myocardial deformation (strain) during systole. Recent clinical studies explored the prognostic role of left ventricular global longitudinal strain (GLS). However, there are few data on the association between cardiovascular outcome and GLS in the community. Therefore, we hypothesized that GLS contains additive prognostic information over and beyond traditional cardiovascular risk factors in a large, population-based cohort. Methods and Results-We measured GLS by 2-dimensional speckle tracking in the apical 4-chamber view in 791 participants (mean age 50.9 years). We calculated multivariable adjusted hazard ratios for midwall, endocardial, and epicardial GLS, while accounting for family cluster and cardiovascular risk factors. Median follow-up was 7.9 years (5th to 95th percentile, 3.7-9.6). In continuous analysis, with adjustments applied for covariables, midwall, endocardial, and epicardial GLS were significant predictors of fatal and nonfatal cardiovascular (n=96; P<0.0001) and cardiac events (n=68; P≤0.001). In the sex-specific low quartile of midwall GLS (<18.8% in women and <17.4% in men), the risk was significantly higher than the average population risk for cardiovascular (128%, P<0.0001) and cardiac (94%, P=0.0007) events. We also noticed that the risk for cardiovascular events increased with increasing number of left ventricular abnormalities, such as low GLS, diastolic dysfunction, and hypertrophy (log-rank P<0.0001). Conclusions-Low GLS measured by 2-dimensional speckle tracking predicts future cardiovascular events independent of conventional risk factors. Left ventricular midwall strain represents a simple echocardiographic measure, which might be used for assessing cardiovascular risk in a population-based cohort. (Circ Cardiovasc Imaging. 2016;9:e004661.
M yocardial remodeling starts before the onset of overt cardiac disease. Therefore, recent guidelines place special emphasis on detecting subclinical left ventricular (LV) systolic and diastolic dysfunction (LVDD) because it might contribute to the stratification of cardiovascular risk. 1 The echocardiographic techniques to assess early changes in systolic and diastolic LV function evolved rapidly over the past years. 2 Recently applied techniques of Tissue Doppler Imaging (TDI) and 2-dimensional (2D) speckle tracking provide additional information about cardiac function in addition to conventional echocardiographic measurements. An early stage of LV dysfunction is characterized by less vigorous LV longitudinal systolic deformation (strain) and mitral annulus motion (TDI e′) during early diastole. 3, 4 See Clinical Perspective LV Systolic Dysfunction as Predictor of Outcome no study demonstrated the independent predictive value of GLS for the incidence of the composite atherosclerotic cardiovascular and cardiac events in the general population. We hypothesized that GLS contains additive prognostic information over and beyond traditional cardiovascular risk factors in a large population-based cohort.
Methods

Study Participants
The Ethics Committee of the University of Leuven approved the Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO), a large family-based population resource on the genetic epidemiology of cardiovascular phenotypes. 13, 14 From August 1985 to December 2005, we identified a random population sample stratified by sex and age from a geographically defined area in northern Belgium as described in the Data Supplement. 13, 14 From 2005 to 2009, we invited 1031 former participants for a technical examination at our field center, including echocardiography. We obtained informed written consent from 828 subjects (participation rate, 80%). To study the incidence of mortality and morbidity in relation to baseline LV systolic dysfunction, we collected outcome data on average 7.9 years after their first echocardiographic examination. For the current analysis, we further excluded 37 subjects because of atrial fibrillation (n=8), the presence of an artificial pacemaker (n=3), or because of GLS (n=22) or diastolic function (n=4) could not be reliably determined. Thus, the outcome cohort included 791 participants.
Echocardiography
Echocardiographic methods are detailed in Methods section in the Data Supplement.
Data Acquisition
One experienced physician (T. Kuznetsova) did the ultrasound examination 14, 15 using a Vivid7 Pro (GE Vingmed, Horten, Norway) interfaced with a 2.5-to 3.5-MHz phased-array probe, according to the recent recommendations. 16, 17 With the subjects in partial left decubitus and breathing normally, the observer obtained images, together with a simultaneous ECG signal, along the parasternal long and short axes and from the apical 4-and 2-chamber long-axis views. All recordings included at least 5 cardiac cycles and were digitally stored for offline analysis.
Offline Analysis
The postprocessing of echocardiograms was performed by an observer (T. Kuznetsova) blinded to the participants' characteristics and before collecting information on outcome. Digitally stored images were analyzed using a workstation running the EchoPac software, version BT113 (GE Vingmed, Horten, Norway). All measurements were averaged over 3 heart cycles for statistical analysis. End-diastolic LV dimensions were used to calculate LV mass by using an anatomically validated formula. 16 LV hypertrophy (LVH) was an LV mass index of 52 g/m 2.7 in men and 45 g/m 2.7 in women or more. We combined the mitral inflow and TDI velocities and its ratios to classify the stages of LVDD at baseline as described previously (Methods in the Data Supplement). 14, 15 For measurement of 2D GLS strain, at least 2 cardiac cycles with the best image quality was selected. The endocardial border was manually traced with the point-and-click option at the end-systolic frame of the 2D images from the apical 4-chamber view. A region of interest was constructed according to the requirements of the software (Q-analysis, EchoPac BT113). We used default settings of the 2D strain module of the software, including smoothing of the data which automatically tracks myocardial speckle motion, creating basal, mid, and apical regions of interest. Manual adjustments were made after visual inspection of the segmental tracking results throughout the cardiac cycle, with the goal of obtaining the best possible tracking in all myocardial segments. The width of the region of interest was also adjusted locally to myocardial thickness if needed. We excluded images from further analysis if tracking was insufficient in ≥2 segments, which also correspond to the software suggestions after the wall segmentation. The peak systolic endocardial, midwall, and epicardial GLS values were automatically provided by the software. For statistical analysis, we used their absolute values.
Assessment of Outcome
Outcomes were adjudicated against source documents, as described in previous publications. 15, 18 We ascertained vital status of FLEMENGHO participants until December 31, 2014. During follow-up, 38 participants died. We obtained the International Classification of Disease codes for the immediate and underlying cause of death. 15, 18 We collected information on the incidence of nonfatal events via a follow-up visit (n=665) or a telephone interview (n=103), with repeat administration of the same standardized questionnaire used at baseline. In all participants (n=791), we also checked and ascertained information on diseases against the medical records of general practitioners and in the regional hospitals. Coronary events included fatal and nonfatal myocardial infarction, coronary revascularization, and new-onset angina (stable or unstable). Cardiac events included coronary events, fatal and nonfatal HF, pulmonary heart disease, new-onset atrial fibrillation, and life-threatening arrhythmias. Fatal and nonfatal cardiovascular events comprised cardiac end points, stroke, transient ischemic attack, aortic aneurysm, arterial embolism, and revascularization of peripheral arteries. To assess the symptoms associated with HF, we administered the standardized London School of Hygiene Cardiovascular, Dyspnea and Respiratory Questionnaires. 19 In the study participants who experienced cardiovascular events, we only considered the first event per participant.
A complete description of other measurements is provided in the Methods section in the Data Supplement.
Statistical Methods
For database management and statistical analysis, we used SAS software, version 9.3 (SAS Institute, Cary, NC). We compared means and proportions by means of a large-sample z test and the χ 2 statistics, respectively. Statistical significance was a 2-sided significance level of 0.05.
In exploratory analyses, we plotted incidence rates by sex-specific quartiles of the LV GLS at baseline, while standardizing for sex and age (age groups: <40 years; 40-60 years; >60 years) by the direct method. We used Cox regression to compute standardized hazard ratios, which express the risk associated with a 1-standard deviation (SD) change in GLS. The baseline characteristics considered as covariables in Cox regression were sex, age, body mass index, systolic blood pressure, smoking, serum cholesterol, antihypertensive treatment, diabetes mellitus, and a history of cardiac disease. We checked the proportional hazard assumption using the Kolmogorov-type supremum test. Clustering of failure times within pedigrees was taken into account by fitting a sheared frailty model. In the categorical analyses, we used the Kaplan-Meier method for estimation of cumulative incidence according to the quartiles of LV midwall strain and to the groups with 0, 1, 2, or 3 LV abnormalities on echocardiography, including abnormal LV midwall strain, LVDD, and LVH. We also expressed the risk in each GLS quartile relative to the overall risk in the whole study population, which allowed computation of confidence intervals for the hazard ratio in each quartile without definition of an arbitrary reference group.
Finally, we assessed the added ability of midwall GLS to predict fatal and nonfatal cardiovascular events, using the integrated discrimination improvement and the net reclassification improvement as described by Pencina et al. 20 
Results
Characteristics of Participants at Baseline
The population-based cohort consisted of 791 white Europeans of whom 410 (51.8%) were women, 326 (41.2%) had hypertension, and 202 were taking blood pressure-lowering drugs. Mean age was 50.8 (SD 15.5) years. At baseline, 167 participants (21.1%) were current smokers and 43 (5.4%) and 34 (4.3%) had a history of cardiac diseases and diabetes mellitus, respectively. Five participants (0.6%) had baseline EF The sex-specific distributions of GLS measured at the midwall, endocardial, and epicardial levels of LV wall are shown in Figure I in the Data Supplement. Overall, women had significantly higher LV strains compared with men (P<0.0001), with a mean LV midwall strain in women of 20.3% (interquartile range: 18.8%-21.7%) versus 18.7% (interquartile range: 17.4%-20.1%). Table 1 shows the baseline clinical and echocardiographic characteristics of the study participants by quartiles of LV midwall strain. Participants with low LV midwall strain were older and had a higher prevalence of cardiovascular risk factors, including hypertension, previous cardiac disease, higher body mass index, and total cholesterol (P<0.05 for all; Table 1 ). Moreover, LVH and LVDD were more prevalent in subjects with low LV midwall strain as compared with the rest of the cohort (Table 1 )
Incidence of Events
In our population-based cohort, the median follow-up was 7.9 years (5th to 95th percentile, 3.7-9.6). During 5729 personyears of follow-up, 96 participants experienced at least one fatal or nonfatal cardiovascular end point (16.8 events per 1000 person-years). A fatal or nonfatal cardiac and coronary events occurred in 68 (11.7 events per 1000 person-years) and 34 (5.7 events per 1000 person-years) participants, respectively. Table 2 lists the cause-specific cardiovascular mortality and morbidity for the study cohort. Only the first event within every category was considered in the outcome analyses. Figure 1 shows the sex-and age-standardized incidence rates for fatal and nonfatal cardiovascular end points across sexspecific quartiles of GLS measured at midwall, endocardial, and epicardial levels of LV wall. The risk for all cardiovascular events increased across decreasing LV midwall strain quartiles: from 11 in the high (incidence rate, 6.9/1000 person-years), 12 in the high-medium (10.9/1000 person-years), 22 in the medium-low (18.9/1000 person-years), and 51 in the low quartile (37.1/1000 person-years). The same trend was observed for cardiac and coronary events (Figure 1 ). Analyses of the GLS measured at epicardial and endocardial levels of LV wall produced confirmatory results. Figure II in the Data Supplement demonstrates the Kaplan-Meier cumulative incidence of composite cardiovascular and cardiac events in quartiles of LV midwall strain (log-rank test; P<0.0001). On the contrary, we did not observe any significant increase in the risk for outcome across quartiles of EF (P≥0.36; Figure III in the Data Supplement). Table 3 shows the multivariable adjusted hazard ratios associated with every SD decrease in GLS. With adjustments applied for family clusters, sex, age, body mass index, systolic blood pressure, serum cholesterol, current smoking, antihypertensive drug treatment, diabetes mellitus, and a history of cardiac disease, GLS measured at any level of LV wall was a significant predictor of fatal and nonfatal cardiovascular (P<0.0001), cardiac (P≤0.0010), and coronary events (P<0.0001; Table 3 ). The increases in the risks of cardiovascular, cardiac, and coronary events associated with a 1-SD decrease (2.5%) in LV midwall strain were 75% (P<0.0001), 54% (P=0.0041), and 144% (P<0.0001), respectively (Table 3) .With further adjustment for LV mass index or TDI e′ velocity (as continuous variables), the results were confirmatory (Table 3) . Moreover, the LV GLS measured at endocardial and epicardial levels of LV wall had similar prognostic significance for any adverse events (P≤0.006; Table 3 ). All Cox models complied with the proportional hazards assumption. In a sensitivity analysis, after exclusion of participants with a history of cardiac diseases (n=43), our findings remained consistent (Table III in the Data Supplement). Figure 2 shows the multivariable adjusted cumulative incidence estimates for cardiovascular events by sex-specific quartiles of LV midwall strain and the adjusted hazard ratios expressing the risk in each quartile compared with the averaged risk in the whole cohort. Only in the lower quartile group, the risk was significantly higher than the average risk for Figure 2C and 2D). The results of these analyses suggest that for LV midwall GLS, values <18.8% in women and <17.4% in men might be associated with an increased risk of a cardiovascular event. Hazard ratios (HR) express the risk per standard deviation (SD) decrease in strain parameters (2.5%, 2.9%, and 2.2%, respectively). The Cox modes included family clusters, sex, age, body mass index, systolic blood pressure, serum cholesterol, smoking, antihypertensive treatment, diabetes mellitus, and a history of cardiac disease. In fully adjusted models, left ventricular mass index and e′ were additionally included. CI indicates confidence interval; GLS, global longitudinal strain; LV indicates left ventricular; and TDI, Tissue Doppler Imaging. LV Systolic Dysfunction as Predictor of Outcome Eighty-three (40.5%) participants out of 205 with LV midwall strain below the proposed thresholds had either LVDD (n=14) or LVH (n=37) or both abnormalities (n=32; Figure 3 , upper panel). We noticed that the risk for cardiovascular and cardiac events increased with increasing number of having any of three LV abnormalities (Figure 3, lower panel) . Figure 4 also demonstrates higher cumulative incidence of composite cardiovascular and cardiac events with increasing number of LV abnormalities (log-rank test P<0.0001).
Risk Associated With LV GLS
Additive Value of LV Midwall Strain in Improving Prognostic Accuracy
For fatal and nonfatal cardiovascular events (P=0.015), integrated discrimination improvement reached significance by adding LV midwall strain to the basic clinical model ( Table 4 ). The category-free net reclassification improvement for the addition of LV midwall strain in predicting all cardiovascular events was 0.31 (95% confidence interval: 0.10-0.52; P=0.0033), representing a moderate improvement of the ability of the Cox model to discriminate between subjects with and without cardiovascular events (Table 4 ).
Discussion
The key findings of this study is that after adjustment for conventional cardiovascular risk factors, GLS measured at any of the 3 levels of LV wall is a predictor of fatal and nonfatal cardiovascular and cardiac events in a population-based cohort. P values are for trend across the 4 quartiles of LV global longitudinal strain (GLS). Incidence was standardized to the mean values of the covariables (sex, age, body mass index, systolic blood pressure, serum cholesterol, current smoking, antihypertensive drug treatment, diabetes mellitus, and a history of cardiac disease) in the total study population. C and D, Multivariable adjusted hazard ratios (95% CI) for cardiovascular (C) and cardiac (D) events by sex-specific quartiles of LV midwall strain (GLS) in 791 subjects. The hazard ratios express the risks in quartiles compared with the average risk in the whole cohort and were adjusted as described earlier. CI indicates confidence interval.
We also demonstrated that after full adjustment for important covariables, participants belonging to the low sex-specific quartile of LV midwall strain had significantly increased risks of all cardiovascular events as compared with the average risk in the whole cohort. As quantified by the integrated discrimination improvement and net reclassification improvement statistics, LV GLS improved the discrimination between subjects with and without cardiovascular events as compared with a model including only conventional cardiovascular risk factors. Furthermore, the risk for cardiovascular events increased with higher number of LV echocardiographic abnormalities, such as abnormal LV midwall strain, LVDD, and LVH.
Echocardiography plays a central role in the evaluation of LV systolic function. In addition to conventional echocardiography together with measurements of LV volumes and EF, the 2D speckle tracking technique opens up the possibility of noninvasively evaluating myocardial deformation (strain). 12 Recent clinical studies explored the prognostic role of these new LV strain indexes. Three studies [5] [6] [7] in patients with symptomatic HF and reduced EF demonstrated that low LV GLS is superior to EF in identifying patients with poor outcomes, such as all-cause or cardiac mortality and recurrent hospitalization for HF. In the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, 8 GLS was a powerful predictor of HF hospitalization, cardiovascular death, or resuscitated cardiac arrest in a cohort of 447 HF patients with preserved EF. The authors demonstrated that in an adjusted model, a 1 unit decrease in GLS was associated with a 14% increment in risk of primary outcomes (P=0.003), and they proposed a cut-off of 15.8% for GLS. 8 Two studies 9, 10 reported that assessment of GLS also provided important prognostic information in patients with acute myocardial infarction and preserved EF above traditional risk factors. Furthermore, in 546 patients undergoing clinically indicated echocardiography to investigate known or suspected LV impairment (mean age, 61 years; 35% with previous myocardial infarction), Stanton et al 21 demonstrated that GLS was superior to EF and wall motion score index for the prediction of the all-cause mortality.
Two community-based studies explored in continuous analyses the prognostic role of the different LV deformation indexes. 1, 2, 11 In 1768, asymptomatic participants (mean age, 65 years) enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA), 11 LV circumferential strain assessed by magnetic resonance imaging provided incremental predictive value for incident HF. In this study, the author did not measure GLS. 11 In the Framingham Heart Study (n=2831; mean age, 66 years), 12 LV GLS was borderline associated with incident coronary heart events (hazards ratio per SD increment 1.29; P=0.05), whereas circumferential strain was a significant predictor of incident HF (1.79; P<0.0001). Decrements in longitudinal and circumferential strain were significantly related to all-cause mortality in the Framingham study. 12 In our study, we assessed the prognostic utility of LV GLS because, as indicated in the recently published Task Force, 22 it appears to be the most robust echocardiographic metric as compared with circumferential and radial strain, and therefore, it might be easily implemented in clinical practice. There are also concurrent definitions which are used as a basis for GLS calculations using endocardial, midwall, epicardial deformation or even averaged strain. We demonstrated that GLS measured at any of the 3 levels of LV wall is a significant predictor of fatal and nonfatal cardiovascular and cardiac events after adjustment for important clinical covariables as well as for LVMI and TDI e′.
In our study, subjects belonging to the low sex-specific quartile of the distribution of the LV midwall strain (<18.8% in women and <17.4% in men) were older and more likely to have risk factors, such as hypertension, previous history of cardiac disease, higher body mass index, and total cholesterol. Although adjusting for these risk factors in multivariable Cox models, only in the lower GLS quartile group, the risk for cardiovascular and cardiac events was significantly higher than The basic model include as covariables sex, age, body mass index, systolic blood pressure, serum cholesterol, smoking, diabetes mellitus, and history of cardiac disease (see Table 3 ). The integrated discrimination improvement (IDI) and the net reclassification improvements (NRI) reflect the improvements in discriminative power by adding LV midwall strain to a Cox model already including the above covariables. CI indicates confidence interval; and LV, left ventricle. for the differences between groups by the log-rank test. HR is the multivariable adjusted hazard ratio as described in Figure 2 . CI indicates confidence interval. LV Systolic Dysfunction as Predictor of Outcome the average population risk. Our findings suggest that the LV GLS might contribute to risk stratification. On the contrary, our results are in line with previous clinical studies demonstrating that LV GLS is superior to EF in identifying patients with poor outcomes. [8] [9] [10] 21 The association of GLS with cardiovascular outcomes after adjustment for LVMI and TDI e′ is important because ≈40% of the participants in our cohort with abnormally low midwall GLS also had low TDI e′ and elevated E/e′ (indicators of LVDD) or LVH. Both LVDD 15 and LVH 23 are known prognostic markers in the community. Incidence rate of the composite cardiovascular events increased with increasing number of the LV abnormalities, suggesting that all these features (abnormal GLS, LVDD, and LVH) are useful for risk stratification in the community. Therefore, the comprehensive assessment of cardiac function and structure in which GLS plays a major role would be important for risk stratification.
Our study has to be interpreted within the context of its potential limitations and strengths. First, echocardiographic measurements are prone to error. In the present study, one experienced observer recorded all echocardiographic images using a highly standardized imaging protocol. All digitally stored images were centrally postprocessed by a single observer. Second, our sample size was smaller than that in published community-based studies. However, the research question addressed in this study and our conclusions extend the findings of previous publications in patients with HF [5] [6] [7] [8] or at risk. 21 Third, we included in our analysis 43 (5.4%) participants with a previous history of cardiac diseases. In a sensitivity analysis, after exclusion of participants with previous cardiac diseases, our findings remained consistent. Fourth, we estimated GLS only from the apical 4-chamber view. We might therefore have underestimated the full spectrum of GLS among all LV views. Indeed, it is advisable to interrogate all 3 apical views if there is suspicion of regional myocardial dysfunction because of ischemia or myocardial infarction. On the contrary, Farsalinos et al reported a strong correlation between averaged GLS from 3 long-axes views and GLS from the 4-chamber view (r=0.92; P<0.001) in patients referred to the routine echocardiography in the University hospital. 24 Fifth, the reported strain values were obtained with GE equipment only. Because of the relevant differences between GLS measurements performed with software of different vendors, 24 our values may not be directly compared with measurements from other equipment.
In conclusion, low GLS measured by 2D speckle tracking significantly predicted fatal and nonfatal cardiovascular events. LV midwall strain represents a simple echocardiographic measure which might be used for assessing cardiovascular risk in a population-based cohort.
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